Home LiteratureArticle Details
PMID: 10669724 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

Regulatory and signaling properties of the Vav family.

Molecular and cellular biology ·Vol. 20 ·No. 5 ·2000-03-00 ·Pages 1461-77

Bustelo XR

Abstract

暂无摘要

MeSH Terms
Animals Gene Expression Regulation Humans Oncogene Proteins Proto-Oncogene Proteins c-vav Signal Transduction
Chemicals
Oncogene Proteins Proto-Oncogene Proteins c-vav VAV1 protein, human
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Bustelo X R
Department of Pathology, State University of New York at Stony Brook, Stony Brook, New York 11794, USA. xbustelo@path.som.sunysb.edu
References (172)
172 references, click to expand
  1. BLNK: a central linker protein in B cell activation.
    Immunity. 1998 Jul;9(1):93-103 PMID: 9697839
  2. CH domains revisited.
    FEBS Lett. 1998 Jul 17;431(2):134-7 PMID: 9708889
  3. Co-stimulation-dependent activation of a JNK-kinase in T lymphocytes.
    Eur J Immunol. 1998 Aug;28(8):2320-30 PMID: 9710210
  4. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation.
    Cell. 1998 Jan 9;92(1):83-92 PMID: 9489702
  5. Regulation of inositol lipid kinases by Rho and Rac.
    Curr Opin Genet Dev. 1998 Feb;8(1):63-7 PMID: 9529607
  6. Multiple signalling pathways lead to the activation of the nuclear factor kappaB by the Rho family of GTPases.
    J Biol Chem. 1998 May 22;273(21):12779-85 PMID: 9582304
  7. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor.
    Curr Biol. 1998 May 7;8(10):554-62 PMID: 9601639
  8. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction.
    Curr Biol. 1998 May 7;8(10):563-72 PMID: 9601640
  9. T cell activation through the CD43 molecule leads to Vav tyrosine phosphorylation and mitogen-activated protein kinase pathway activation.
    J Biol Chem. 1998 Jun 5;273(23):14218-24 PMID: 9603925
  10. LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation.
    Immunity. 1998 Aug;9(2):239-46 PMID: 9729044
  11. The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways.
    Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3035-40 PMID: 10077632
  12. Mitogen-activated protein kinases: specific messages from ubiquitous messengers.
    Mol Cell Biol. 1999 Apr;19(4):2435-44 PMID: 10082509
  13. Activation of serum response factor by RhoA is mediated by the nuclear factor-kappaB and C/EBP transcription factors.
    J Biol Chem. 1999 Mar 26;274(13):8506-15 PMID: 10085083
  14. Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity.
    J Immunol. 1999 Mar 15;162(6):3148-52 PMID: 10092764
  15. Essential role of LAT in T cell development.
    Immunity. 1999 Mar;10(3):323-32 PMID: 10204488
  16. hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways.
    Mol Cell Biol. 1999 May;19(5):3798-807 PMID: 10207103
  17. Prolactin receptor signaling: shared components with the T-cell antigen receptor in Nb2 lymphoma cells.
    Endocrine. 1998 Dec;9(3):313-20 PMID: 10221598
  18. G protein beta gamma subunit-dependent Rac-guanine nucleotide exchange activity of Ras-GRF1/CDC25(Mm).
    Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):4826-31 PMID: 10220378
  19. Association of a p95 Vav-containing signaling complex with the FcepsilonRI gamma chain in the RBL-2H3 mast cell line. Evidence for a constitutive in vivo association of Vav with Grb2, Raf-1, and ERK2 in an active complex.
    J Biol Chem. 1996 Oct 25;271(43):26962-70 PMID: 8900182
  20. A human exchange factor for ARF contains Sec7- and pleckstrin-homology domains.
    Nature. 1996 Dec 5;384(6608):481-4 PMID: 8945478
  21. Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product.
    Immunity. 1996 Dec;5(6):591-604 PMID: 8986718
  22. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.
    Nature. 1997 Jan 9;385(6612):169-72 PMID: 8990121
  23. Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases.
    Curr Biol. 1996 Dec 1;6(12):1628-33 PMID: 8994827
  24. Structure and function of vav.
    Cell Signal. 1996 Dec;8(8):545-53 PMID: 9115846
  25. Vav is associated with signal transducing molecules gp130, Grb2 and Erk2, and is tyrosine phosphorylated in response to interleukin-6.
    FEBS Lett. 1997 Jan 20;401(2-3):133-7 PMID: 9013873
  26. Lck regulates Vav activation of members of the Rho family of GTPases.
    Mol Cell Biol. 1997 Mar;17(3):1346-53 PMID: 9032261
  27. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase.
    J Exp Med. 1996 Sep 1;184(3):839-52 PMID: 9064344
  28. p95vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells.
    J Exp Med. 1996 Sep 1;184(3):1161-6 PMID: 9064333
  29. Expression of a novel isoform of Vav, Vav-T, containing a single Src homology 3 domain in murine testicular germ cells.
    Oncogene. 1997 Feb 13;14(6):713-20 PMID: 9038379
  30. Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR zeta/CD3 induction of interleukin-2.
    Immunity. 1997 Feb;6(2):155-64 PMID: 9047237
  31. Tyrosine phosphorylation of the vav proto-oncogene product links FcepsilonRI to the Rac1-JNK pathway.
    J Biol Chem. 1997 Apr 18;272(16):10751-5 PMID: 9099726
  32. The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase.
    Science. 1997 Apr 18;276(5311):418-20 PMID: 9103201
  33. The VAV family of signal transduction molecules.
    Crit Rev Oncog. 1996;7(1-2):65-88 PMID: 9109498
  34. Regulated membrane localization of Tiam1, mediated by the NH2-terminal pleckstrin homology domain, is required for Rac-dependent membrane ruffling and C-Jun NH2-terminal kinase activation.
    J Cell Biol. 1997 Apr 21;137(2):387-98 PMID: 9128250
  35. Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line.
    J Biol Chem. 1995 Jun 2;270(22):13246-53 PMID: 7768923
  36. Tyrosine phosphorylation of vav protooncogene product in primary human myelogenous leukemic cells stimulated by granulocyte colony-stimulating factor.
    Biochem Biophys Res Commun. 1995 Jun 15;211(2):677-85 PMID: 7540842
  37. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP.
    Science. 1995 Jul 14;269(5221):242-4 PMID: 7618087
  38. A functional T-cell receptor signaling pathway is required for p95vav activity.
    Mol Cell Biol. 1995 Aug;15(8):4337-46 PMID: 7623828
  39. Serum response factor: transcriptional regulation of genes induced by growth factors and differentiation.
    Biochim Biophys Acta. 1995 Jul 28;1242(1):1-10 PMID: 7626651
  40. Interleukin 3 and erythropoietin induce association of Vav with Tec kinase through Tec homology domain.
    Oncogene. 1995 Aug 17;11(4):619-25 PMID: 7651724
  41. Interaction of smooth muscle calponin with phospholipids.
    FEBS Lett. 1995 Sep 4;371(2):123-6 PMID: 7672110
  42. TPO and IL-3 induce overlapping but distinct protein tyrosine phosphorylation in a myeloid precursor cell line.
    Biochem Biophys Res Commun. 1995 Sep 14;214(2):424-31 PMID: 7545904
  43. Signal transduction in T lymphocytes using a conditional allele of Sos.
    Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9810-4 PMID: 7568223
  44. The proline-rich region of Vav binds to Grb2 and Grb3-3.
    Oncogene. 1995 Oct 19;11(8):1665-9 PMID: 7478592
  45. Insulin-dependent tyrosine phosphorylation of the vav protooncogene product in cells of hematopoietic origin.
    J Biol Chem. 1995 Mar 31;270(13):7712-6 PMID: 7535775
  46. A requirement for Syk in the activation of the microtubule-associated protein kinase/phospholipase A2 pathway by Fc epsilon R1 is not shared by a G protein-coupled receptor.
    J Biol Chem. 1995 May 5;270(18):10960-7 PMID: 7537741
  47. Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSC1.
    Ann Hum Genet. 1995 Jan;59(Pt 1):25-37 PMID: 7762982
  48. PAK3 mutation in nonsyndromic X-linked mental retardation.
    Nat Genet. 1998 Sep;20(1):25-30 PMID: 9731525
  49. Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
    Oncogene. 1998 Sep 17;17(11 Reviews):1415-38 PMID: 9779988
  50. Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation.
    Oncogene. 1998 Sep 24;17(12):1597-606 PMID: 9794237
  51. c-Cbl: a regulator of T cell receptor-mediated signalling.
    Immunol Cell Biol. 1998 Oct;76(5):473-82 PMID: 9797470
  52. Fyn and ZAP-70 are required for Vav phosphorylation in T cells stimulated by antigen-presenting cells.
    J Biol Chem. 1998 Nov 27;273(48):31932-8 PMID: 9822663
  53. Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2.
    EMBO J. 1998 Nov 16;17(22):6608-21 PMID: 9822605
  54. Vav regulates peptide-specific apoptosis in thymocytes.
    J Exp Med. 1998 Dec 7;188(11):2099-111 PMID: 9841924
  55. Regulation of PAK activation and the T cell cytoskeleton by the linker protein SLP-76.
    Immunity. 1998 Nov;9(5):607-16 PMID: 9846482
  56. LAT is required for TCR-mediated activation of PLCgamma1 and the Ras pathway.
    Immunity. 1998 Nov;9(5):617-26 PMID: 9846483
  57. Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1.
    Curr Biol. 1998 Dec 3;8(24):1289-99 PMID: 9843681
  58. Thymocyte selection in Vav and IRF-1 gene-deficient mice.
    Immunol Rev. 1998 Oct;165:149-66 PMID: 9850859
  59. The Syk family of protein tyrosine kinases in T-cell activation and development.
    Immunol Rev. 1998 Oct;165:167-80 PMID: 9850860
  60. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor.
    Genes Dev. 1998 Dec 1;12(23):3663-74 PMID: 9851973
  61. Interdomain B in ZAP-70 regulates but is not required for ZAP-70 signaling function in lymphocytes.
    Mol Cell Biol. 1999 Jan;19(1):948-56 PMID: 9858619
  62. Activation of Vav and Ras through the nerve growth factor and B cell receptors by different kinases.
    Cell Immunol. 1999 Feb 1;191(2):83-9 PMID: 9973529
  63. Adaptors and molecular scaffolds in immune cell signaling.
    Cell. 1999 Jan 8;96(1):5-8 PMID: 9989491
  64. BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells.
    Immunity. 1999 Jan;10(1):117-25 PMID: 10023776
  65. Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation.
    EMBO J. 1999 Feb 15;18(4):904-15 PMID: 10022833
  66. A novel PDZ domain containing guanine nucleotide exchange factor links heterotrimeric G proteins to Rho.
    J Biol Chem. 1999 Feb 26;274(9):5868-79 PMID: 10026210
  67. Rac1 is required for the formation of three germ layers during gastrulation.
    Oncogene. 1998 Dec 31;17(26):3427-33 PMID: 10030666
  68. Defective immunoglobulin class switching in Vav-deficient mice is attributable to compromised T cell help.
    Eur J Immunol. 1999 Feb;29(2):477-87 PMID: 10064063
  69. Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense.
    Immunity. 1999 Feb;10(2):183-96 PMID: 10072071
  70. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase.
    Nature. 1999 Mar 4;398(6722):84-90 PMID: 10078535
  71. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
    J Immunol. 1999 Jul 15;163(2):802-10 PMID: 10395673
  72. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway.
    J Immunol. 1999 Jul 15;163(2):844-53 PMID: 10395678
  73. PAR1 activation initiates integrin engagement and outside-in signalling in megakaryoblastic CHRF-288 cells.
    Biochim Biophys Acta. 1999 Jul 8;1450(3):265-76 PMID: 10395938
  74. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics.
    Cell. 1999 Jul 23;98(2):159-69 PMID: 10428028
  75. N-terminally truncated Vav induces the formation of depolymerization-resistant actin filaments in NIH 3T3 cells.
    FEBS Lett. 1999 Jul 16;455(1-2):123-9 PMID: 10428485
  76. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.
    Science. 1999 Oct 8;286(5438):309-12 PMID: 10514377
  77. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins.
    Mol Cell Biol. 1999 Nov;19(11):7870-85 PMID: 10523675
  78. The small GTP-binding protein Rho potentiates AP-1 transcription in T cells.
    Mol Cell Biol. 1998 Sep;18(9):4986-93 PMID: 9710582
  79. Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors.
    Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):179-84 PMID: 10618391
  80. A guanine nucleotide exchange factor-independent function of Vav1 in transcriptional activation.
    J Biol Chem. 2000 Jan 21;275(3):2185-90 PMID: 10636924
  81. Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav.
    Mol Cell Biol. 2000 Mar;20(5):1678-91 PMID: 10669745
  82. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells.
    EMBO J. 1989 Aug;8(8):2283-90 PMID: 2477241
  83. Rho GTPases are over-expressed in human tumors.
    Int J Cancer. 1999 May 31;81(5):682-7 PMID: 10328216
  84. SLP-76 and Vav function in separate, but overlapping pathways to augment interleukin-2 promoter activity.
    J Biol Chem. 1999 Jun 4;274(23):16206-12 PMID: 10347175
  85. The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28-mediated co-stimulation.
    Eur J Immunol. 1999 May;29(5):1709-18 PMID: 10359126
  86. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    J Immunol. 1999 Jun 15;162(12):7088-94 PMID: 10358152
  87. Functional analysis of LAT in TCR-mediated signaling pathways using a LAT-deficient Jurkat cell line.
    Int Immunol. 1999 Jun;11(6):943-50 PMID: 10360968
  88. Signaling networks--do all roads lead to the same genes?
    Cell. 1999 Jun 11;97(6):675-8 PMID: 10380918
  89. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling.
    Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13158-62 PMID: 9371816
  90. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation.
    Oncogene. 1997 Nov 20;15(21):2511-20 PMID: 9399639
  91. The thrombopoietin receptor can mediate proliferation without activation of the Jak-STAT pathway.
    J Exp Med. 1997 Dec 15;186(12):1947-55 PMID: 9396763
  92. Growth factor receptor-bound protein 2 SH2/SH3 domain binding to CD28 and its role in co-signaling.
    J Biol Chem. 1998 Jan 2;273(1):296-301 PMID: 9417079
  93. Rho GTPases and the actin cytoskeleton.
    Science. 1998 Jan 23;279(5350):509-14 PMID: 9438836
  94. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav.
    Science. 1998 Jan 23;279(5350):558-60 PMID: 9438848
  95. Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos.
    Science. 1998 Jan 23;279(5350):560-3 PMID: 9438849
  96. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas.
    Br J Cancer. 1998;77(1):147-52 PMID: 9459160
  97. Signaling through CD5 activates a pathway involving phosphatidylinositol 3-kinase, Vav, and Rac1 in human mature T lymphocytes.
    Mol Cell Biol. 1998 Mar;18(3):1725-35 PMID: 9488489
  98. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav.
    Immunity. 1998 May;8(5):635-45 PMID: 9620684
  99. p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13.
    Science. 1998 Jun 26;280(5372):2109-11 PMID: 9641915
  100. Colony-stimulating factor-1 stimulates the formation of multimeric cytosolic complexes of signaling proteins and cytoskeletal components in macrophages.
    J Biol Chem. 1998 Jul 3;273(27):17128-37 PMID: 9642280
  101. Membrane compartmentation is required for efficient T cell activation.
    Immunity. 1998 Jun;8(6):723-32 PMID: 9655486
  102. Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes.
    Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8193-8 PMID: 9653163
  103. Uncoupling of nonreceptor tyrosine kinases from PLC-gamma1 in an SLP-76-deficient T cell.
    Science. 1998 Jul 17;281(5375):413-6 PMID: 9665884
  104. Cytoskeletal reorganization by G protein-coupled receptors is dependent on phosphoinositide 3-kinase gamma, a Rac guanosine exchange factor, and Rac.
    Mol Cell Biol. 1998 Aug;18(8):4744-51 PMID: 9671484
  105. The Vav-Rac1 pathway in cytotoxic lymphocytes regulates the generation of cell-mediated killing.
    J Exp Med. 1998 Aug 3;188(3):549-59 PMID: 9687532
  106. Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76.
    Cell. 1998 Jul 24;94(2):229-38 PMID: 9695951
  107. CD19 regulates B lymphocyte responses to transmembrane signals.
    Semin Immunol. 1998 Aug;10(4):267-77 PMID: 9695183
  108. Vav links antigen-receptor signaling to the actin cytoskeleton.
    Semin Immunol. 1998 Aug;10(4):317-27 PMID: 9695188
  109. Substrate specificities and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase.
    Oncogene. 1994 Jun;9(6):1755-65 PMID: 8183574
  110. Ternary complex factors: growth factor regulated transcriptional activators.
    Curr Opin Genet Dev. 1994 Feb;4(1):96-101 PMID: 8193547
  111. ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency.
    Science. 1994 Jun 10;264(5165):1599-601 PMID: 8202713
  112. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes.
    Oncogene. 1994 Jul;9(7):1917-23 PMID: 8208538
  113. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
    Oncogene. 1994 Aug;9(8):2405-13 PMID: 8036025
  114. The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras.
    J Exp Med. 1994 Sep 1;180(3):1067-76 PMID: 7520466
  115. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway.
    Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8602-6 PMID: 8078929
  116. Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras.
    Mol Cell Biol. 1994 Oct;14(10):6848-57 PMID: 7935402
  117. CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line.
    Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9347-51 PMID: 7524075
  118. Isolation and characterization of the faciogenital dysplasia (Aarskog-Scott syndrome) gene: a putative Rho/Rac guanine nucleotide exchange factor.
    Cell. 1994 Nov 18;79(4):669-78 PMID: 7954831
  119. IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases.
    J Exp Med. 1994 Dec 1;180(6):2101-11 PMID: 7525847
  120. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor.
    Blood. 1994 Dec 15;84(12):4135-41 PMID: 7527668
  121. Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors.
    J Biol Chem. 1994 Dec 23;269(51):32514-21 PMID: 7528218
  122. The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav.
    J Biol Chem. 1994 Dec 23;269(51):32579-85 PMID: 7798261
  123. Binding of Vav to Grb2 through dimerization of Src homology 3 domains.
    Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12629-33 PMID: 7809090
  124. Hematopoietic development of vav-/- mouse embryonic stem cells.
    Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12755-9 PMID: 7809116
  125. The human VAV proto-oncogene maps to chromosome region 19p12----19p13.2.
    Hum Genet. 1990 Nov;86(1):65-8 PMID: 2253939
  126. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.
    Mol Cell Biol. 1991 Apr;11(4):1912-20 PMID: 2005887
  127. Mechanism of activation of the vav protooncogene.
    Cell Growth Differ. 1991 Feb;2(2):95-105 PMID: 2069873
  128. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates.
    Nature. 1992 Mar 5;356(6364):68-71 PMID: 1311423
  129. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs.
    Nature. 1992 Mar 5;356(6364):71-4 PMID: 1531699
  130. Differential development of progenitor activity for three B-cell lineages.
    Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3320-4 PMID: 1565622
  131. Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells.
    Science. 1992 May 22;256(5060):1196-9 PMID: 1375396
  132. Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells.
    J Biol Chem. 1992 Sep 5;267(25):18021-5 PMID: 1381360
  133. Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck.
    Biochem J. 1993 Sep 1;294 ( Pt 2):339-42 PMID: 7690544
  134. Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells.
    Mol Cell Biol. 1993 Oct;13(10):6572-85 PMID: 7692230
  135. Cross-linking of Fc gamma receptor I (Fc gamma RI) and receptor II (Fc gamma RII) on monocytic cells activates a signal transduction pathway common to both Fc receptors that involves the stimulation of p72 Syk protein tyrosine kinase.
    J Biol Chem. 1993 Nov 15;268(32):24442-8 PMID: 8226994
  136. Proteins regulating Ras and its relatives.
    Nature. 1993 Dec 16;366(6456):643-54 PMID: 8259209
  137. Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells.
    J Biol Chem. 1994 Feb 4;269(5):3143-6 PMID: 7508909
  138. 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans.
    Nature. 1994 Mar 3;368(6466):32-8 PMID: 7906398
  139. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav.
    Mol Cell Biol. 1994 Apr;14(4):2777-85 PMID: 7511210
  140. Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes.
    Oncogene. 1996 Jul 18;13(2):363-71 PMID: 8710375
  141. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
    Oncogene. 1996 Aug 1;13(3):455-60 PMID: 8760286
  142. Differential regulation of activation-induced tyrosine phosphorylation and recruitment of SLP-76 to Vav by distinct isoforms of the CD45 protein-tyrosine phosphatase.
    J Biol Chem. 1996 Sep 6;271(36):22225-30 PMID: 8703037
  143. Ras effectors.
    Curr Opin Cell Biol. 1996 Apr;8(2):197-204 PMID: 8791426
  144. The Dbl family of oncogenes.
    Curr Opin Cell Biol. 1996 Apr;8(2):216-22 PMID: 8791419
  145. Vav in natural killer cells is tyrosine phosphorylated upon cross-linking of Fc gamma RIIIA and is constitutively associated with a serine/threonine kinase.
    Biochem J. 1996 Sep 1;318 ( Pt 2):527-32 PMID: 8809042
  146. Functional analysis of the cytoplasmic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation.
    FEBS Lett. 1996 Oct 21;395(2-3):228-34 PMID: 8898102
  147. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig.
    J Immunol. 1997 Jun 15;158(12):5649-57 PMID: 9190913
  148. Proto-oncoprotein Vav interacts with c-Cbl in activated thymocytes and peripheral T cells.
    J Immunol. 1997 Jul 1;159(1):70-6 PMID: 9200440
  149. Signal transduction during natural killer cell activation: inside the mind of a killer.
    Immunity. 1997 Jun;6(6):655-61 PMID: 9208838
  150. Three domains of SLP-76 are required for its optimal function in a T cell line.
    J Immunol. 1997 Aug 15;159(4):1639-47 PMID: 9257823
  151. Rho GTPases and signaling networks.
    Genes Dev. 1997 Sep 15;11(18):2295-322 PMID: 9308960
  152. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes.
    Immunity. 1997 Oct;7(4):451-60 PMID: 9354466
  153. The Janus protein tyrosine kinases in hematopoietic cytokine signaling.
    Semin Immunol. 1995 Aug;7(4):247-54 PMID: 8520029
  154. Does Vav bind to F-actin through a CH domain?
    FEBS Lett. 1995 Oct 30;374(2):149-51 PMID: 7589522
  155. TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including proto-oncogene products, Vav and c-Cbl, and Ras signaling molecules.
    Biochem Biophys Res Commun. 1995 Nov 2;216(1):338-47 PMID: 7488109
  156. Megakaryocyte growth and development factor and interleukin-3 induce patterns of protein-tyrosine phosphorylation that correlate with dominant differentiation over proliferation of mpl-transfected 32D cells.
    Blood. 1995 Dec 15;86(12):4532-43 PMID: 8541543
  157. Thrombopoietin induces activation of at least two distinct signaling pathways.
    FEBS Lett. 1995 Dec 27;377(3):497-501 PMID: 8549784
  158. Interaction of calponin with phospholipids.
    J Biochem. 1995 May;117(5):999-1003 PMID: 8586646
  159. Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product.
    Exp Hematol. 1996 Apr;24(5):622-7 PMID: 8605967
  160. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization.
    Cell. 1996 Mar 8;84(5):723-34 PMID: 8625410
  161. Thrombin receptor activation and integrin engagement stimulate tyrosine phosphorylation of the proto-oncogene product, p95vav, in platelets.
    J Biol Chem. 1996 Mar 29;271(13):7544-50 PMID: 8631786
  162. The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells.
    J Biol Chem. 1996 Feb 16;271(7):3856-62 PMID: 8632004
  163. Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation.
    Immunity. 1996 Jun;4(6):593-602 PMID: 8673706
  164. Transcription factors of the NFAT family: regulation and function.
    Annu Rev Immunol. 1997;15:707-47 PMID: 9143705
  165. The Vav binding site (Y315) in ZAP-70 is critical for antigen receptor-mediated signal transduction.
    J Exp Med. 1997 May 19;185(10):1877-82 PMID: 9151714
  166. Crystal structure of a calponin homology domain.
    Nat Struct Biol. 1997 Mar;4(3):175-9 PMID: 9164454
  167. The GTPase Rho has a critical regulatory role in thymus development.
    EMBO J. 1997 May 1;16(9):2397-407 PMID: 9171353
  168. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
    Cell Immunol. 1997 May 1;177(2):119-28 PMID: 9178638
  169. Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL.
    EMBO J. 1995 Jan 16;14(2):257-65 PMID: 7530656
  170. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav.
    Nature. 1995 Mar 30;374(6521):467-70 PMID: 7700358
  171. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene.
    Nature. 1995 Mar 30;374(6521):470-3 PMID: 7700359
  172. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+ CD8+ thymocytes.
    Nature. 1995 Mar 30;374(6521):474-7 PMID: 7700360
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
DOI
10.1128/MCB.20.5.1461-1477.2000
Email
xbustelo@path.som.sunysb.edu
Published
2000-03-00
Pages
1461-77
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC85310
Subset
IM
Grants
NCI NIH HHS · CA7373501 · United States
External Links
PubMed source DOI: 10.1128/MCB.20.5.1461-1477.2000 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2